CD33 and Alzheimer disease: Broadly, AD risk genes are associated with lipid transport (APOE, CLU), transmembrane signalling (SORL1, TREM2, CD33, MS4A6A), and membrane and cytoskeletal dynamics (INPP5D, PLCG2, BIN1, CASS4).